{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:29:54Z","timestamp":1783024194790,"version":"3.54.6"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    A 33-year-old woman presented with intermittent fever for 1 month, accompanied by pancytopenia and multiple enlarged lymph nodes in the bilateral neck, axillary and para-iliac regions on ultrasound. With informed consent, the patient was enrolled in a clinical trial comparing\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG and\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Pentixafor PET\/CT for lymph node lesions. In contrast to the negative\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT findings,\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Pentixafor PET\/CT showed high tracer uptake in these lymph nodes. Subsequent cervical lymph node excision biopsy revealed reactive lymphoid hyperplasia; combined with elevated anti-ds-DNA, anti-SS-A, and anti-RNP titers, lupus lymphadenitis was diagnosed. After antisystemic lupus erythematosus therapy, the lymph nodes regressed significantly.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006397","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:07:42Z","timestamp":1774894062000},"page":"685-686","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Lupus Lymphadenitis With Intense Pentixafor Avidity But Absent FDG Uptake"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3618-1180","authenticated-orcid":false,"given":"Runze","family":"Duan","sequence":"first","affiliation":[{"name":"Hebei Medical University"},{"name":"Department of Nuclear Medicine, Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian yue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhu","family":"Bian","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06076.x","article-title":"PET\/CT imaging in systemic lupus erythematosus","volume":"1228","author":"Curiel","year":"2011","journal-title":"ANN NY Acad Sci"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0961203306071916","article-title":"Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia","volume":"15","author":"Garc\u00eda-Valladares","year":"2006","journal-title":"Lupus"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/13543784.2020.1797677","article-title":"Type I interferon antagonists in clinical development for lupus","volume":"29","author":"Paredes","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/RLU.0000000000001802","article-title":"Generalized lymph node FDG uptake as the first manifestation of systemic lupus erythematosus","volume":"42","author":"Girard","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"15264","DOI":"10.1038\/s41598-024-65256-1","article-title":"Comparative analysis of F-18 FDG PET\/CT images between scrub typhus and systemic lupus erythematosus","volume":"14","author":"Han","year":"2024","journal-title":"Sci Rep"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1097\/RLU.0000000000005379","article-title":"Comparing the diagnostic value of FDG PET or PET\/CT with FDG PET\/MR in inflammatory bowel disease: a systematic review and meta-analysis","volume":"49","author":"Lin","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLU.0000000000005806","article-title":"Medium-vessel vasculitis on FDG-PET\/CT at initial presentation and relapse","volume":"50","author":"Vion","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"1490593","DOI":"10.3389\/fimmu.2024.1490593","article-title":"The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models","volume":"15","author":"Bekaddour","year":"2024","journal-title":"Front Immunol"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"e2303300","DOI":"10.1002\/adhm.202303300","article-title":"CXCR4-expressing mesenchymal stem cells derived nanovesicles for rheumatoid arthritis treatment","volume":"13","author":"Gan","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1038\/s41467-023-41484-3","article-title":"CREB1-driven CXCR4hi neutrophils promote skin inflammation in mouse models and human patients","volume":"14","author":"Chen","year":"2023","journal-title":"Nat Commun"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:10:28Z","timestamp":1783023028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006397","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"2026-01-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}